Literature DB >> 33658073

Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities.

Yun-Xing Fu1, Jing Ji1, Fang Shan1, Jialing Li1, Rong Hu2.   

Abstract

Premature ovarian failure (POF) is one of the common disorders found in women leading to 1% female infertility. Clinical features of POF are hypoestrogenism or estrogen deficiency, increased gonadotropin level, and, most importantly, amenorrhea. With the development of regenerative medicine, human mesenchymal stem cell (hMSC) therapy brings new prospects for POF. This study aimed to describe the types of MSCs currently available for POF therapy, their biological characteristics, and their mechanism of action. It reviewed the latest findings on POF to provide the theoretical basis for further investigation and clinical therapy.

Entities:  

Keywords:  Mesenchymal stem cells; Ovarian function; Premature ovarian failure

Year:  2021        PMID： 33658073      PMCID： PMC7931610          DOI： 10.1186/s13287-021-02212-0

Source DB:  PubMed          Journal:  Stem Cell Res Ther        ISSN： 1757-6512            Impact factor:   6.832


  146 in total

Review 1.  Treatment of premature menopause in breast cancer patients.

Authors:  G Deniz; C Antoine; F Liebens; B Carly; A Pastijn; S Rozenberg
Journal:  Acta Chir Belg       Date:  2007-06       Impact factor: 1.090

2.  Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.

Authors:  Te Liu; Fuhui Xu; Xiling Du; Dongmei Lai; Tianjin Liu; Yarui Zhao; Qin Huang; Lizhen Jiang; Wenbin Huang; Weiwei Cheng; Zhixue Liu
Journal:  Mol Cell Biochem       Date:  2010-03-12       Impact factor: 3.396

3.  Transplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertility.

Authors:  Lijun Ding; Guijun Yan; Bin Wang; Lu Xu; Yan Gu; Tong Ru; Xiaoying Cui; Lei Lei; Jingyu Liu; Xiaoqiang Sheng; Bin Wang; Chunxue Zhang; Yanjun Yang; Ruiwei Jiang; Jianjun Zhou; Na Kong; Feifei Lu; Huaijun Zhou; Yannan Zhao; Bing Chen; Yali Hu; Jianwu Dai; Haixiang Sun
Journal:  Sci China Life Sci       Date:  2018-03-13       Impact factor: 6.038

Review 4.  Sex hormone replacement in ovarian failure - new treatment concepts.

Authors:  Jenifer Sassarini; Mary Ann Lumsden; Hilary O D Critchley
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2014-10-02       Impact factor: 4.690

5.  Homing and restorative effects of bone marrow-derived mesenchymal stem cells on cisplatin injured ovaries in rats.

Authors:  Jiabin Liu; Haiying Zhang; Yun Zhang; Nan Li; Yuku Wen; Fanglei Cao; Hao Ai; Xiaoou Xue
Journal:  Mol Cells       Date:  2014-11-10       Impact factor: 5.034

6.  Exosomes derived from human adipose mesenchymal stem cells improve ovary function of premature ovarian insufficiency by targeting SMAD.

Authors:  Boxian Huang; Jiafeng Lu; Chenyue Ding; Qinyan Zou; Wei Wang; Hong Li
Journal:  Stem Cell Res Ther       Date:  2018-08-09       Impact factor: 6.832

7.  Dimethyloxaloylglycine-stimulated human bone marrow mesenchymal stem cell-derived exosomes enhance bone regeneration through angiogenesis by targeting the AKT/mTOR pathway.

Authors:  Bo Liang; Jia-Ming Liang; Jia-Ning Ding; Jia Xu; Jian-Guang Xu; Yi-Min Chai
Journal:  Stem Cell Res Ther       Date:  2019-11-20       Impact factor: 6.832

Review 8.  The role of autoimmunity in premature ovarian failure.

Authors:  Mahbod Ebrahimi; Firouzeh Akbari Asbagh
Journal:  Iran J Reprod Med       Date:  2015-08

9.  Human chorionic plate-derived mesenchymal stem cells transplantation restores ovarian function in a chemotherapy-induced mouse model of premature ovarian failure.

Authors:  Jun Li; Qingtong Yu; Haisen Huang; Wenwen Deng; Xia Cao; Michael Adu-Frimpong; Jiangnan Yu; Ximing Xu
Journal:  Stem Cell Res Ther       Date:  2018-04-03       Impact factor: 6.832

10.  Endometrial mesenchymal stem cells isolated from menstrual blood repaired epirubicin-induced damage to human ovarian granulosa cells by inhibiting the expression of Gadd45b in cell cycle pathway.

Authors:  Zhongrui Yan; Fengyi Guo; Qing Yuan; Yu Shao; Yedan Zhang; Huiyan Wang; Shaohua Hao; Xue Du
Journal:  Stem Cell Res Ther       Date:  2019-01-03       Impact factor: 6.832
View more
  6 in total

1.  MicroRNA-146 attenuates lipopolysaccharide induced ovarian dysfunction by inhibiting the TLR4/NF- κB signaling pathway.

Authors:  Fengping He; Yanhui Liu; Tang Li; Qiulin Ma; Zhang Yongmei; Peiqing He; Chuanyin Xiong
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 2.  Research Progress on the Treatment of Premature Ovarian Failure Using Mesenchymal Stem Cells: A Literature Review.

Authors:  Jing Wang; Wanru Liu; Dehai Yu; Zongxing Yang; Sijie Li; Xiguang Sun
Journal:  Front Cell Dev Biol       Date:  2021-12-13

3.  Human Amniotic Fluid Mesenchymal Stem Cell-Derived Exosomes Inhibit Apoptosis in Ovarian Granulosa Cell via miR-369-3p/YAF2/PDCD5/p53 Pathway.

Authors:  Zixiang Geng; Haiyang Chen; Gang Zou; Long Yuan; Peng Liu; Bingrong Li; Kaiyong Zhang; Fangyuan Jing; Xiaoli Nie; Te Liu; Bimeng Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-07-26       Impact factor: 7.310

4.  Melatonin enhances autologous adipose-derived stem cells to improve mouse ovarian function in relation to the SIRT6/NF-κB pathway.

Authors:  Qiao-Yi Huang; Shao-Rong Chen; Yun-Xia Zhao; Jia-Ming Chen; Wei-Hong Chen; Shu Lin; Qi-Yang Shi
Journal:  Stem Cell Res Ther       Date:  2022-08-04       Impact factor: 8.079

5.  miR-126-3p containing exosomes derived from human umbilical cord mesenchymal stem cells promote angiogenesis and attenuate ovarian granulosa cell apoptosis in a preclinical rat model of premature ovarian failure.

Authors:  Qingxi Qu; Linghong Liu; Yuqian Cui; Hongli Liu; Jingyang Yi; Weidong Bing; Chunxiao Liu; Detian Jiang; Yanwen Bi
Journal:  Stem Cell Res Ther       Date:  2022-07-26       Impact factor: 8.079

Review 6.  Current Research on Complementary and Alternative Medicine in the Treatment of Premature Ovarian Failure: An Update Review.

Authors:  Yue Li; Meng-Yu Yan; Qiao-Chu Chen; Ya-Ya Xie; Chen-Yu Li; Feng-Juan Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-23       Impact factor: 2.650
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.